ATORVASTATIN-D5 LACTONE

ATORVASTATIN-D5 LACTONE Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Light Yellow Solid

Verwenden

Labelled Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation.

ATORVASTATIN-D5 LACTONE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ATORVASTATIN-D5 LACTONE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32344	50
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-83725681-603		China	4505	50
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1958	55
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226	sales@rrkchem.com	China	56086	58
Shenzhen ruikai de biotechnology co., ltd.	0755-61348847 17820674378	2682116078@qq.com	China	7844	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58
Guangzhou Juntang Technology Co., Ltd	020-36607679 13502246435	sales@dmstandards.com	China	10951	58

1217749-86-4()Verwandte Suche:

---

• ATORVASTATIN-D5 LACTONE
• 5-(4-Fluorophenyl)-2-(1-methylethyl)-N-phenyl-(4-phenyl-d5)-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
• Atorvastatin-d5 d-Lactone
• 1217749-86-4
• C33H28D5FN2O4
• Inhibitors
• Intermediates & Fine Chemicals
• Isotope Labeled Compounds
• Metabolites & Impurities
• Pharmaceuticals
• Isotope Labelled Compounds
• All Inhibitors